期刊文献+

效应性T细胞亚群Th17与动脉粥样硬化 被引量:4

New Subset of Effector T Cells Th17 and Atherosclerosis
下载PDF
导出
摘要 效应性T细胞亚群Th17是新近发现的效应性T细胞的又一亚群,因分泌细胞因子IL-17而得名。Th17通过分泌多种效应分子如白细胞介素17、17F、21和肿瘤坏死因子-α等与慢性炎症性疾病、自身免疫性疾病和肿瘤等疾病密切相关。研究发现,动脉粥样硬化的发生发展也与Th17功能的异常密切相关,现拟就此进行综述。 Th17 characterized by the production of interleukin(IL)-17 is a newly founded subset of CD4 T effect cells.Th17 cytokines include IL-17,IL-17F,IL-21,tumor nuclear factor-α and so on.Th17 have been linked to many chronic inflammatory diseases,autoimmune diseases and tumor.Several data indicated that Th17 response may play an important role in the development and progression of atherosclerosis.In this review,we will introduce the role of Thl 7 in atherosclerosis.
出处 《心血管病学进展》 CAS 2011年第2期238-241,共4页 Advances in Cardiovascular Diseases
基金 国家自然科学基金项目资助(No:81070237)
关键词 效应性T细胞 TH17 动脉粥样硬化 effector T cells Th17 atherosclerosis
  • 相关文献

参考文献20

  • 1Hansson GK, Jonasson L. The discovery of cellular immunity in the atherosclerotic plaque[ J]. Arterioscler Thromb Vasc Biol, 2009,29 ( 11 ) : 1714-1717.
  • 2Packard RR, Lichtman AH, Libby P. Innate and adaptive immunity in atherosclerosis[ J]. Semin Immunopathol, 2009,31 ( 1 ) :5-22.
  • 3Lundberg AM, Hansson GK. Innate immune signals in athemsclerosis[J]. Clin Immunol, 2010,134( 1 ) :5-24.
  • 4Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis [ J ]. Clin Immunol, 201 O, 134 ( 1 ) : 33 -46.
  • 5Harrlngton LE, Hatton RD, Mangan PR,et al. Interleukin 17-producing CIM + effector T cells develop via a lineage distinct from the T helper type 1 and 2 line- ages[ J]. Nat Immunol, 2005,6 ( 11 ) : 1123-1132.
  • 6Park H, Li Z, Yang XO, et al. A distinct lineage of C1M T cells regulates tissue inflammation by producing interleukin 17 [ J]. Nat Immunol, 2005,6 ( 11 ) : 1133-1141.
  • 7Sakoda M,Ichihara A,Kurauchi-Mito A,Narita T,Kinou-chi K,Murohashi-Bokuda K,Saleem MA,Nishiyama A,Suzuki F,Itoh H,黄晓斌.在不影响人足细胞(前)肾素受体信号下,阿利吉仑能抑制细胞内血管紧张素Ⅱ水平[J].中华高血压杂志,2010,18(7):698-698. 被引量:18
  • 8de Jong E, Suddason T, Lord GM. Translational mini-review series on Thl7 cells: development of mouse and human T helper 17 cells [ J ]. Clin Exp Immu- nol, 2010,159(2) :148-158.
  • 9Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin6 and interleukin-8 in unstable coronary artery disease [ J ]. Coron Artery Dis, 2006,17(8) :699-706.
  • 10Cheng X, Yu X, Ding YJ, et al. The Thl7/Treg imbalance in patients with a- cute coronary syndrome[J]. Clin Immunol,2008,127 (1) :89-97.

共引文献17

同被引文献75

  • 1Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease : challenges and opportunities [J]. Science, 2013, 339(6116) :166-172.
  • 2Lichtman AH, Binder C J, Tsimikas S, et al. Adaptive immunity in atherogene-sis: new insights and therapeutic approaches [ J]. J Clin Invest, 2013, 123 (1) :27-36.
  • 3Libby P. Inflammation in atherasclerosis[ J]. Artefioscler Thromb Vase Biol, 2012, 32(9) :2045-2051.
  • 4Nold MF, Nold-Petry CA, Zepp JA, et al. IL-37 is a fundamental inhibitor of innate immunity [J]. Nat Immunol, 2010, 11(11) : 1014-1022.
  • 5Boraschi D, Lucchesi D, Hainzl S, et al. IL-37 : a new anti-inilammatory cyto- kine of the IL-1 family [J]. Eur Cyokine Netw, 2011,22(3) : 127-147.
  • 6Pan G, Rieser P, Man W, et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp [J]. Cytoklne, 2001, 13(1):1-7.
  • 7Sharma S, Kulk N, Nold MF, et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines [ J ]. J ImmunoI, 2008, 180(8) : 5477-5482.
  • 8McNamee EN, Mesterson JC, Jedlicka P, et al. Interleukin 37 expression pro- tecta mice from colitis [J]. Proc Nail Acad Sci USA, 2011, 108(40) : 16711- 16716.
  • 9Sakai N, van Sweringen HL, Belizaire RM, et al. Interleukin-37 reduces liver inflasmatory injury via effects on hepatocytes and non-parennhymal cells [J]. J Gastroeaterol Hepatol, 2012, 27(10): 1609-1616.
  • 10Kumar S, Hanning CR, Brigham-Burke MR, et al. Interleuldn-lF7B (1L- 1HI/IL-IFT) ie processed by caspsse-1 and mature IL-1FTB binds to the IL- 18 receptor but does not induce IFN-gsmma production [ J]. Cytokine, 2002, 18(2) : 61-71.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部